BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 30385172)

  • 1. Predicting severe acute radiation pneumonitis in patients with non-small cell lung cancer receiving postoperative radiotherapy: Development and internal validation of a nomogram based on the clinical and dose-volume histogram parameters.
    Tang X; Li Y; Tian X; Zhou X; Wang Y; Huang M; Ren L; Zhou L; Xue J; Ding Z; Zhu J; Xu Y; Peng F; Wang J; Lu Y; Gong Y
    Radiother Oncol; 2019 Mar; 132():197-203. PubMed ID: 30385172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
    Zhou Y; Yan T; Zhou X; Cao P; Luo C; Zhou L; Xu Y; Liu Y; Xue J; Wang J; Wang Y; Lu Y; Liang B; Gong Y
    Strahlenther Onkol; 2020 Jun; 196(6):505-514. PubMed ID: 31828393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Nomogram and Risk Classification System Predicting Radiation Pneumonitis in Patients With Esophageal Cancer Receiving Radiation Therapy.
    Wang L; Liang S; Li C; Sun X; Pang L; Meng X; Yu J
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1074-1085. PubMed ID: 31461673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the predictors for radiation pneumonitis in patient with non-small cell lung cancer received radiotherapy after pneumonectomy.
    Yu JH; Wang CL; Liu Y; Wang JM; Lv CX; Liu J; Zhang Q; Fu XL; Cai XW
    Cancer Radiother; 2021 Jun; 25(4):323-329. PubMed ID: 33446419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
    Willner J; Jost A; Baier K; Flentje M
    Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive model of the first failure pattern in patients receiving definitive chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (LA-NSCLC).
    Zhu X; Hou R; Li X; Jiang C; Xia W; Fu X
    Radiat Oncol; 2020 Feb; 15(1):43. PubMed ID: 32070383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic Radiation Pneumonitis in NSCLC Patients Receiving EGFR-TKIs and Concurrent Once-daily Thoracic Radiotherapy: Predicting the Value of Clinical and Dose-volume Histogram Parameters.
    Yang X; Mei T; Yu M; Gong Y
    Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):409-419. PubMed ID: 35747920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Shi A; Zhu G; Wu H; Yu R; Li F; Xu B
    Radiat Oncol; 2010 May; 5():35. PubMed ID: 20462424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel nomogram containing acute radiation esophagitis predicting radiation pneumonitis in thoracic cancer receiving radiotherapy.
    Tang W; Li X; Yu H; Yin X; Zou B; Zhang T; Chen J; Sun X; Liu N; Yu J; Xie P
    BMC Cancer; 2021 May; 21(1):585. PubMed ID: 34022830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
    Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.
    Tsujino K; Hashimoto T; Shimada T; Yoden E; Fujii O; Ota Y; Satouchi M; Negoro S; Adachi S; Soejima T
    J Thorac Oncol; 2014 Jul; 9(7):983-990. PubMed ID: 24922010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine Learning to Build and Validate a Model for Radiation Pneumonitis Prediction in Patients with Non-Small Cell Lung Cancer.
    Yu H; Wu H; Wang W; Jolly S; Jin JY; Hu C; Kong FS
    Clin Cancer Res; 2019 Jul; 25(14):4343-4350. PubMed ID: 30992302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram based on circulating lymphocyte subsets for predicting radiation pneumonia in esophageal squamous cell carcinoma.
    Zhang XZ; Tao SP; Liang SX; Chen SB; Liu FS; Jiang W; Chen MJ
    Front Immunol; 2022; 13():938795. PubMed ID: 36105795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data.
    Bradley JD; Hope A; El Naqa I; Apte A; Lindsay PE; Bosch W; Matthews J; Sause W; Graham MV; Deasy JO;
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):985-92. PubMed ID: 17689035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
    Katsui K; Ogata T; Watanabe K; Katayama N; Soh J; Kuroda M; Kiura K; Maeda Y; Toyooka S; Kanazawa S
    BMC Cancer; 2019 Nov; 19(1):1144. PubMed ID: 31771538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma.
    Boonyawan K; Gomez DR; Komaki R; Xu Y; Nantavithya C; Allen PK; Mohan R; Liao Z
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):919-926. PubMed ID: 29976504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non-small cell lung cancer: Analysis of dose-volume parameters.
    Katsui K; Ogata T; Watanabe K; Katayama N; Kuroda M; Kiura K; Hiraki T; Maeda Y; Toyooka S; Kanazawa S
    Cancer Med; 2020 Jul; 9(13):4540-4549. PubMed ID: 32364685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk analysis of grade ≥ 2 radiation pneumonitis based on radiotherapy timeline in stage III/IV non-small cell lung cancer treated with volumetric modulated arc therapy: a retrospective study.
    Yang S; Huang S; Ye X; Xiong K; Zeng B; Shi Y
    BMC Pulm Med; 2022 Nov; 22(1):402. PubMed ID: 36344945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel model integrating computed tomography-based image markers with genetic markers for discriminating radiation pneumonitis in patients with unresectable stage III non-small cell lung cancer receiving radiotherapy: a retrospective multi-center radiogenomics study.
    Li J; Li L; Tang S; Yu Q; Liu W; Liu N; Yang F; Zhang D; Yuan S
    BMC Cancer; 2024 Jan; 24(1):78. PubMed ID: 38225543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.